Article
FDA News
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
When the world went virtual: How ophthalmology’s conferences stayed on track
(EyePod) From idea to impact: Navigating ophthalmic innovation
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China
Formosa Pharmaceuticals enters into licensing agreement with Cipla for commercialization of APP13007 across 11 countries